OOS Management
Leading OOS management software for structured Phase I and Phase II out of specification investigation aligned to FDA guidance — a GMP OOS investigation software with LIMS integration, decision-tree protocols, and complete regulatory defensibility as a GxP laboratory investigation software.
30%
Faster Investigation
FDA
Compliant Framework
Phase I/II
Automated Workflows
LIMS
Integrated
End-to-End Process Flow
How It Works
Structured workflow from initiation through closure with built-in compliance checkpoints and regulatory defensibility at every stage.
OOS Detection
Automated OOS trigger from LIMS integration when test results exceed specification limits, with immediate notification to supervisors within this FDA compliant OOS management platform.
Phase I Investigation
Checklist-driven lab deviation investigation system reviewing sample handling, instrument calibration, reagent validity, and analyst technique as part of structured out of specification investigation.
Phase I Decision
Determine if assignable laboratory cause found — if yes, document and re-test; if no, escalate to Phase II within this GMP OOS investigation software.
Phase II Investigation
GxP laboratory investigation software with expanded investigation covering manufacturing process review, batch record analysis, environmental data, and material traceability.
Re-testing & Disposition
Execute re-testing and re-sampling protocols with predefined decision trees and acceptance criteria for batch disposition within this regulatory compliant OOS system.
Closure & Trending
Complete out of specification investigation with supervisor and QA approval, auto-generate deviations and CAPAs, and feed trending analytics through this OOS management software.
Capabilities
Key Features
Comprehensive capabilities designed for Life Sciences regulatory requirements and operational excellence.
Automated OOS trigger from LIMS integration when test results exceed specification limits within this FDA compliant OOS management platform
Phase I (Laboratory Investigation): Checklist-driven lab deviation investigation system reviewing sample handling, instrument calibration, reagent validity, and analyst technique
Phase II (Full-Scale Investigation): GxP laboratory investigation software covering manufacturing process review, batch record analysis, and environmental data
Re-testing and re-sampling protocols with predefined decision trees and acceptance criteria as part of this regulatory compliant OOS system
Auto-generation of deviation and CAPA records when assignable cause is identified through out of specification investigation
Supervisor review and QA approval workflows with electronic signatures at each phase within this GMP OOS investigation software
Trending of OOS events by test method, product, laboratory, and analyst for systemic root cause identification via this lab deviation investigation system
Real-World Applications
Use Cases
Proven scenarios where this module delivers measurable value across Life Sciences operations.
Finished Product Release Testing
Investigate OOS results during batch release testing using this lab deviation investigation system, determine root cause, and make scientifically justified batch disposition decisions.
Stability Study Failure
Manage out of specification investigation results from stability studies with impact assessment on shelf life, regulatory filings, and distributed product via FDA compliant OOS management.
Raw Material Testing
Investigate incoming material OOS results with GxP laboratory investigation software, coordinate with supplier, and assess impact on scheduled production batches.
In-Process Control Failure
Handle in-process OOS results with real-time batch impact assessment, process hold decisions, and root cause investigation within this GMP OOS investigation software.
Common Questions
Frequently Asked Questions
Stay Ahead in Life Sciences
Get the latest product updates, compliance news, and industry insights delivered to your inbox.